• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种使用转移淋巴结比率联合甲状腺球蛋白的逐步方法,用于定制[F]FDG-PET/CT检查指征,以检测甲状腺乳头状癌患者的持续性疾病。

A Stepwise Approach Using Metastatic Lymph Node Ratio-Combined Thyroglobulin for Customization of [F]FDG-PET/CT Indication to Detect Persistent Disease in Patients with Papillary Thyroid Cancer.

作者信息

Piao Hong Hua, Jeon Subin, Yoo Su Woong, Ryu Young Jae, Kim Dong-Yeon, Pyo Ayoung, Bom Hee-Seung, Min Jung-Joon, Kwon Seong Young

机构信息

Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, Hwasun-gun 58128, Korea.

Department of Surgery, Chonnam National University Medical School and Hwasun Hospital, Hwasun-gun 58128, Korea.

出版信息

Diagnostics (Basel). 2021 May 6;11(5):836. doi: 10.3390/diagnostics11050836.

DOI:10.3390/diagnostics11050836
PMID:34066574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8148441/
Abstract

We investigated whether an indication for [F]FDG-PET/CT to detect FDG-avid persistent disease (PD) could be identified precisely using the extent of metastatic lymph nodes (MLNs) and serum thyroglobulin (Tg) in papillary thyroid cancer (PTC) patients. This retrospective study included 429 PTC patients who underwent surgery and radioactive iodine (RAI) therapy. [F]FDG-PET/CT and serum Tg were evaluated just before RAI therapy. The MLN ratio (LNR) was defined as the ratio of the number of MLNs to the number of removed LNs. To derive the LNR-combined criteria, different Tg cut-off values for identifying the PET/CT-indicated group for PD detection were applied individually to subgroups initially classified based on LNR cut-off values. The cut-off values for serum Tg, the number of MLNs, and LNR for a PET/CT indication were 6.0 ng/mL, 5, and 0.51, respectively. Compared to a single parameter (serum Tg, total number of MLNs, and LNR), the LNR-combined criteria showed significantly superior diagnostic performance in detecting FDG-avid PD ( < 0.001). The diagnostic performance of PET/CT in detecting FDG-avid PD was significantly improved when the PET/CT-indicated group was identified through the LNR-combined criteria in a stepwise manner; this can contribute to a customized PET/CT indication in PTC patients.

摘要

我们研究了在甲状腺乳头状癌(PTC)患者中,能否通过转移淋巴结(MLN)的范围和血清甲状腺球蛋白(Tg)精确确定[F]FDG-PET/CT检测FDG摄取阳性的持续性疾病(PD)的指征。这项回顾性研究纳入了429例接受手术和放射性碘(RAI)治疗的PTC患者。在RAI治疗前评估[F]FDG-PET/CT和血清Tg。MLN比率(LNR)定义为MLN数量与切除淋巴结数量的比值。为得出LNR联合标准,将用于识别PET/CT指示的PD检测组的不同Tg临界值分别应用于最初根据LNR临界值分类的亚组。PET/CT指征的血清Tg、MLN数量和LNR的临界值分别为6.0 ng/mL、5和0.51。与单一参数(血清Tg、MLN总数和LNR)相比,LNR联合标准在检测FDG摄取阳性的PD方面显示出显著优越的诊断性能(<0.001)。当通过LNR联合标准逐步识别PET/CT指示组时,PET/CT检测FDG摄取阳性的PD的诊断性能显著提高;这有助于为PTC患者定制PET/CT指征。

相似文献

1
A Stepwise Approach Using Metastatic Lymph Node Ratio-Combined Thyroglobulin for Customization of [F]FDG-PET/CT Indication to Detect Persistent Disease in Patients with Papillary Thyroid Cancer.一种使用转移淋巴结比率联合甲状腺球蛋白的逐步方法,用于定制[F]FDG-PET/CT检查指征,以检测甲状腺乳头状癌患者的持续性疾病。
Diagnostics (Basel). 2021 May 6;11(5):836. doi: 10.3390/diagnostics11050836.
2
PROGNOSTIC VALUE OF LYMPH NODE UPTAKE ON PRETREATMENT F-18 FDG PET/CT IN PATIENTS WITH N1B PAPILLARY THYROID CARCINOMA.N1b 期滤泡状甲状腺癌患者术前 F-18 FDG PET/CT 淋巴结摄取的预后价值。
Endocr Pract. 2019 Aug;25(8):787-793. doi: 10.4158/EP-2018-0607. Epub 2019 Apr 23.
3
Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer.低危或中危组甲状腺乳头状癌患者碘-131 消融后 SPECT/CT 中放射性碘摄取阳性转移淋巴结的危险因素。
PLoS One. 2018 Aug 17;13(8):e0202644. doi: 10.1371/journal.pone.0202644. eCollection 2018.
4
Both F-18 FDG-avidity and Malignant Shape of Cervical Lymph Nodes on PET/CT after Total Thyroidectomy Predict Resistance to High-dose I-131 Therapy in Patients with Papillary Thyroid Cancer.全甲状腺切除术后PET/CT检查中,F-18 FDG摄取及颈部淋巴结的恶性形态均提示甲状腺乳头状癌患者对大剂量I-131治疗耐药。
Asia Ocean J Nucl Med Biol. 2013 Spring;1(1):6-13. doi: 10.7508/aojnmb.2013.01.003.
5
Clinical Usefulness of F-18 FDG PET/CT in Papillary Thyroid Cancer with Negative Radioiodine Scan and Elevated Thyroglobulin Level or Positive Anti-thyroglobulin Antibody.F-18氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(F-18 FDG PET/CT)在放射性碘扫描阴性且甲状腺球蛋白水平升高或抗甲状腺球蛋白抗体阳性的乳头状甲状腺癌中的临床应用价值
Nucl Med Mol Imaging. 2016 Jun;50(2):130-6. doi: 10.1007/s13139-015-0378-5. Epub 2015 Oct 22.
6
Combined role of lymph node ratio and serum thyroglobulin levels in predicting prognosis of papillary thyroid carcinoma.淋巴结比联合血清甲状腺球蛋白水平在预测甲状腺乳头状癌预后中的作用。
Nucl Med Commun. 2020 Aug;41(8):733-739. doi: 10.1097/MNM.0000000000001214.
7
Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.氟-18氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对复发性乳头状甲状腺癌患者的预后影响
Head Neck. 2018 Jan;40(1):94-102. doi: 10.1002/hed.24967. Epub 2017 Nov 11.
8
The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan.18F-氟脱氧葡萄糖正电子发射断层扫描在血清甲状腺球蛋白升高且I-131全身扫描阴性的疑似复发性或转移性分化型甲状腺癌患者中的作用
Nucl Med Rev Cent East Eur. 2014;17(2):87-93. doi: 10.5603/NMR.2014.0023.
9
Preablative Stimulated Thyroglobulin Levels Can Predict Malignant Potential and Therapeutic Responsiveness of Subcentimeter-Sized, 18F-fluorodeoxyglucose-Avid Cervical Lymph Nodes in Patients With Papillary Thyroid Cancer.术前刺激甲状腺球蛋白水平可预测甲状腺乳头状癌患者亚厘米大小、18F-氟脱氧葡萄糖摄取的颈部淋巴结的恶性潜能和治疗反应性。
Clin Nucl Med. 2016 Jan;41(1):e32-8. doi: 10.1097/RLU.0000000000000889.
10
Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [F]FDG PET/CT in non-iodine avid differentiated thyroid carcinoma.甲状腺球蛋白倍增时间比甲状腺球蛋白水平更能为非碘难治性分化型甲状腺癌患者选择进行定位[F]FDG PET/CT 的最佳候选者提供一个更好的阈值。
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):461-468. doi: 10.1007/s00259-020-04992-8. Epub 2020 Aug 13.

本文引用的文献

1
Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [F]FDG PET/CT in non-iodine avid differentiated thyroid carcinoma.甲状腺球蛋白倍增时间比甲状腺球蛋白水平更能为非碘难治性分化型甲状腺癌患者选择进行定位[F]FDG PET/CT 的最佳候选者提供一个更好的阈值。
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):461-468. doi: 10.1007/s00259-020-04992-8. Epub 2020 Aug 13.
2
Combined role of lymph node ratio and serum thyroglobulin levels in predicting prognosis of papillary thyroid carcinoma.淋巴结比联合血清甲状腺球蛋白水平在预测甲状腺乳头状癌预后中的作用。
Nucl Med Commun. 2020 Aug;41(8):733-739. doi: 10.1097/MNM.0000000000001214.
3
Impact of Gender and Age on the Prognosis of Differentiated Thyroid Carcinoma: a Retrospective Analysis Based on SEER.
基于 SEER 的研究:性别和年龄对分化型甲状腺癌预后的影响:回顾性分析
Horm Cancer. 2018 Oct;9(5):361-370. doi: 10.1007/s12672-018-0340-y. Epub 2018 Jul 16.
4
Back so soon? Is early recurrence of papillary thyroid cancer really just persistent disease?这么快就回来了?甲状腺乳头状癌的早期复发真的只是持续性疾病吗?
Surgery. 2018 Jan;163(1):118-123. doi: 10.1016/j.surg.2017.05.028. Epub 2017 Nov 8.
5
Patterns of Initial Recurrence in Completely Resected Papillary Thyroid Carcinoma.完全切除的甲状腺乳头状癌的初始复发模式。
Thyroid. 2017 Jul;27(7):908-914. doi: 10.1089/thy.2016.0648. Epub 2017 May 18.
6
Iodine Uptake Patterns on Post-ablation Whole Body Scans are Related to Elevated Serum Thyroglobulin Levels After Radioactive Iodine Therapy in Patients with Papillary Thyroid Carcinoma.甲状腺乳头状癌患者放射性碘治疗后,消融后全身扫描的碘摄取模式与血清甲状腺球蛋白水平升高有关。
Nucl Med Mol Imaging. 2016 Dec;50(4):329-336. doi: 10.1007/s13139-016-0421-1. Epub 2016 May 13.
7
Impact of sex on the clinicopathological characteristics and prognosis of papillary thyroid cancer.性别对甲状腺乳头状癌临床病理特征及预后的影响。
Can J Surg. 2016 Aug;59(4):287-8. doi: 10.1503/cjs.003816.
8
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
9
The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer.重组人促甲状腺素刺激甲状腺球蛋白在分化型甲状腺癌患者随访中的临界值水平
PLoS One. 2015 Jul 31;10(7):e0133852. doi: 10.1371/journal.pone.0133852. eCollection 2015.
10
Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes.甲状腺球蛋白(Tg)检测再探讨:Tg检测、TgAb检测以及结果与临床结局的相关性
J Clin Endocrinol Metab. 2015 Aug;100(8):E1074-83. doi: 10.1210/jc.2015-1967. Epub 2015 Jun 16.